Artiva Biotherapeutics, Inc. Common Stock (ARTV) Stock Price, Quote & AI Analysis
Live ARTV stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Artiva Biotherapeutics, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Artiva Biotherapeutics, Inc. Common Stock (ARTV), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Artiva Biotherapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Artiva Biotherapeutics, Inc. Common Stock Overview
Company information
Company Overview
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Artiva Biotherapeutics, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...